Klimadinon solution for internal approx. 50 and similar items

Short description Pharmacological action: Estrogen-like, anti-climacteric. Has a sedative effect, normalizes the function of the autonomic nervous system. Contributes to the weakening or disappearance of symptoms of malaise during menopause. The therapeutic effect develops gradually and appears after approximately 2 weeks of treatment. Indications: Vegetovascular and mental disorders in menopause, pre- and postmenopause (flushing of the face, excessive sweating, sleep disturbance, increased nervous excitement Compound 100 ml drops contain: active substance: 12 ml of liquid extract of cimicifuga rhizome (Cimicifuga rhizome), which is equivalent to 2.4 g of dried medicinal plant materials. Ethanol content: 35.0 40.0% (v / v). pharmachologic effect Estrogen-like, anti-climacteric and sedative. The active components of the drug bind to estrogen receptors, incl. in the hypothalamus-pituitary-ovary system, which leads to a decrease in the release of LHRH, a decrease in the release of LH by the anterior lobe of the pituitary gland, the elimination of psychoemotional and vegetative-vascular disorders that occur in the pre- and postmenopausal period. The therapeutic effect develops gradually and appears after about 2-4 weeks. Indications Vegetovascular disorders during menopause, pre- and postmenopause (flushing of the face, excessive sweating, sleep disturbances, increased nervous excitability, mood changes, apathy, etc.). Method of administration and dosage Inside, 30 drops or 1 table. (without biting through, drinking a small amount of liquid) 2 times a day (morning and evening, at the same time). The duration of treatment is determined by the doctor. Side effects Allergic reactions are possible. In rare cases, the appearance of pain in the epigastric region, an increase in body weight is possible. Very rarely - the appearance of a feeling of tension in the mammary glands and menstrual bleeding. Contraindications For drops and tablets: hypersensitivity; estrogen-dependent tumors. With care: liver disease, epilepsy, diseases and brain injuries (use is possible only after consulting a doctor). For drops additionally: alcoholism. For tablets additionally: lactose intolerance. Overdose Cases of overdose and intoxication are currently unknown. special instructions Without consulting a doctor, the drug should not be taken for more than 3 months. When used in recommended doses, the drug does not affect the speed of reaction when driving vehicles and mechanisms. When pregnancy occurs, you must stop taking the drug and consult a doctor. The oral drops contain 35-40% ethanol (by volume). When using the bottle, keep it upright. During the storage of drops, a slight precipitate or slight turbidity may occur, which does not affect the effectiveness of the drug. Oral drops should be shaken before use. Indication for diabetics. Patients with diabetes mellitus can take the drug, because a single dose of this drug contains less than 0.04 XE. Interaction with other drugs Interactions with other drugs are currently unknown. Storage conditions T = + (15-25) C